Carbohydrate vaccines: developing sweet solutions to sticky situations?
about
Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune ResponsesUsing lectins in biomarker research: addressing the limitations of sensitivity and availabilityTargeting host-derived glycans on enveloped viruses for antibody-based vaccine designGlycans, galectins, and HIV-1 infectionThe use of glycoinformatics in glycochemistryMonitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometryOuter membrane vesicles displaying engineered glycotopes elicit protective antibodiesMultivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycansTechnological Microbiology: Development and ApplicationsCHARMM Drude Polarizable Force Field for Aldopentofuranoses and Methyl-aldopentofuranosides.Glycan microarrays for decoding the glycome.A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.Humoral response to a viral glycan correlates with survival on PROSTVAC-VFSerum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients.Parasite Carbohydrate Vaccines.Glycomic and glycoproteomic analysis of glycoproteins-a tutorial.Synthetic carbohydrate antigens for HIV vaccine design.Chemical labelling of active serum thioester proteins for quantification.Antibody recognition of fluorinated MUC1 glycopeptide antigens.Antibody evasion by a gammaherpesvirus O-glycan shieldVery few substitutions in a germ line antibody are required to initiate significant domain exchange.PolysacDB: a database of microbial polysaccharide antigens and their antibodies.Antibody recognition of cancer-related gangliosides and their mimics investigated using in silico site mapping.Creation of an α-mannosynthase from a broad glycosidase scaffold.Recent advances in computational predictions of NMR parameters for the structure elucidation of carbohydrates: methods and limitations.The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuseLysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis.COSMC is overexpressed in proliferating infantile hemangioma and enhances endothelial cell growth via VEGFR2.Protein-ligand binding region prediction (PLB-SAVE) based on geometric features and CUDA acceleration.Characterization and acceptor preference of a soluble meningococcal group C polysialyltransferase.Neoglycoproteins as carbohydrate antigens: synthesis, analysis, and polyclonal antibody response.Structure-based vaccine design in HIV: blind men and the elephant?Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannoseEffect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.Recent advances in the analysis of macromolecular interactions using the matrix-free method of sedimentation in the analytical ultracentrifugeMultivalent glycoconjugates as anti-pathogenic agentsHow can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathwayPerorally active nanomicellar formulation of quercetin in the treatment of lung cancer
P2860
Q26746887-20E374A4-5E66-434E-A94C-646D5D7CC7CAQ26860433-E6A83919-8002-4C21-BB04-7B307020F370Q28084672-4A4A9738-C36F-457A-8463-C8FCDD75C322Q28265115-61517ADB-D06C-4BCF-8DC1-042FC54B501DQ28727599-E8A7D522-0900-4AB0-BC2C-C2A689580CB2Q28830510-2F7790C8-CA0C-46FE-9C7B-0EDBA90C2C99Q28831290-AB3131ED-82CE-421C-AD4E-C087DC0755A3Q28834483-6BB24AF9-F8FD-44FC-BCCC-744EA372DF7EQ30250972-1C73BD75-03C6-4952-9C72-6B2E2E7219A8Q30960274-8AA11687-E7C5-446C-8AD1-4CD513DA46C3Q31004845-F921EB0F-25F6-4B28-A87F-CBAB10BB5583Q31132248-C7E84BE0-1D86-4454-B0F9-1B230203BFECQ33674367-A24E11CC-AA30-4A64-A7DA-02A9E1D181CFQ33778489-0A6B1215-3FF5-4166-89C9-7AC9B993B50DQ33785863-C24A81B5-CF4B-4469-9A27-4DDCA2C7DAE4Q33875839-F8864DB5-3105-441E-885A-91655BFF201BQ33909079-316FFEF1-426B-45EE-B788-47C370C8B2C6Q33996402-AFB07666-F6F8-4F18-B409-D9EB62471886Q34045866-5DB4FC1D-AEE8-48A1-9922-79F35FB2E848Q34082672-B9BC3832-6300-4694-9094-199F3C353084Q34178341-DFDDA5E3-2FBC-4305-94BD-530E420580ECQ34235351-80C43491-557B-450B-BA0A-BF1D7A64E212Q34247281-FBE5CAB0-655E-46D8-AC14-8CCCE7F3EB9CQ34281309-2FFC756D-01EC-4594-8F57-266209017DC6Q34359877-7D7C8227-C62F-4440-9463-5EDBEDE1B36AQ34476304-4F8A2810-A5E4-4AA0-B0F0-BEAA9A64AA6CQ34555552-EAF5A8A9-AB3D-455F-A5A9-B7E36F470481Q34592757-FA6C0381-A72F-4CF6-BB03-A9792F0AA4C4Q34628474-AC3ABAE8-F9C9-4CB2-A628-7DF3E12E1346Q34740881-A64F9333-98F6-4633-8612-7EA09C754785Q34772502-92AF0333-BA8F-446A-9D28-CADF473CA7FDQ34987048-C6379103-50DF-4165-87D0-776D96F82420Q34992273-842C45E3-7876-4076-A0D0-2033F50E5B37Q35119778-E3A333B3-54B4-414C-AEF3-0F2CE48CDAE0Q35163178-FBE8B0D5-04BF-40D2-91F6-C3AC387E5683Q35237419-33763EDB-BCC8-451F-B07F-B9FE5C93CDC4Q35444698-ED8EF1B2-D974-4A3E-B0C6-24AB7C650E2DQ35653703-91723C19-61A4-48FC-9D87-D9AA7585B15CQ35742481-8BC00F81-4ADE-462D-99B0-2DB35F37B372Q35753059-8FDCD28F-AB71-489F-8E77-5C958E75CA33
P2860
Carbohydrate vaccines: developing sweet solutions to sticky situations?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Carbohydrate vaccines: developing sweet solutions to sticky situations?
@en
Carbohydrate vaccines: developing sweet solutions to sticky situations?
@nl
type
label
Carbohydrate vaccines: developing sweet solutions to sticky situations?
@en
Carbohydrate vaccines: developing sweet solutions to sticky situations?
@nl
prefLabel
Carbohydrate vaccines: developing sweet solutions to sticky situations?
@en
Carbohydrate vaccines: developing sweet solutions to sticky situations?
@nl
P2860
P356
P1476
Carbohydrate vaccines: developing sweet solutions to sticky situations?
@en
P2093
Dennis R Burton
Rena D Astronomo
P2860
P2888
P304
P356
10.1038/NRD3012
P577
2010-04-01T00:00:00Z